These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11815517)

  • 1. Timely addition of insulin to oral therapy for type 2 diabetes.
    Riddle MC
    Diabetes Care; 2002 Feb; 25(2):395-6. PubMed ID: 11815517
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug therapy of diabetes mellitus].
    Kaneko T
    Nihon Naika Gakkai Zasshi; 1993 Mar; 82(3):406-9. PubMed ID: 8315336
    [No Abstract]   [Full Text] [Related]  

  • 3. [Combined therapy with insulin and oral hypoglycemic agents in diabetes mellitus].
    Takamatsu J
    Nihon Rinsho; 1990 Dec; 48 Suppl():1031-7. PubMed ID: 2086864
    [No Abstract]   [Full Text] [Related]  

  • 4. [Combination therapy of oral hypoglycemic agents which enhance the efficacy of insulin therapy].
    Hirose T
    Nihon Rinsho; 2012 May; 70 Suppl 3():669-77. PubMed ID: 22768596
    [No Abstract]   [Full Text] [Related]  

  • 5. [Combined insulin-sulfonylurea in type II diabetes mellitus--an update].
    Ravina A; Minuchin O
    Harefuah; 1987 Nov; 113(10):285-7. PubMed ID: 3326798
    [No Abstract]   [Full Text] [Related]  

  • 6. [Combination therapy with insulin and sulfonylurea].
    Takamatsu J
    Nihon Rinsho; 1997 Nov; 55 Suppl():255-60. PubMed ID: 9434477
    [No Abstract]   [Full Text] [Related]  

  • 7. Combination therapy for NIDDM: has its time arrived?
    Menke J
    S D J Med; 1995 Aug; 48(8):246-7. PubMed ID: 7569874
    [No Abstract]   [Full Text] [Related]  

  • 8. [Combination therapy with insulin and sulfonylurea].
    Takamatsu J
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():442-6. PubMed ID: 12387031
    [No Abstract]   [Full Text] [Related]  

  • 9. Combining insulin and oral agents.
    Buse J
    Am J Med; 2000 Apr; 108 Suppl 6a():23S-32S. PubMed ID: 10764847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fear of the injection must not be an argument. Every second type 2 diabetic patient needs insulin].
    MMW Fortschr Med; 2002 Dec; 144(49):60. PubMed ID: 12577748
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral hypoglycaemic agents. When, how and why.
    Harris P; Colagiuri S
    Aust Fam Physician; 1997 Apr; 26(4):391-6. PubMed ID: 9115112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The UK Prospective Diabetes Study.
    Kerner W
    Lancet; 1998 Dec; 352(9144):1934. PubMed ID: 9863811
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacologic profile of oral antidiabetic agents].
    Okubo M; Yamane K; Kohno N
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():310-6. PubMed ID: 12387011
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical inquiries. What is the role of combination therapy (insulin plus oral medication) in type 2 diabetes?
    Eskesen S; Kelsberg G; Hitchcock K; Lo V
    J Fam Pract; 2006 Nov; 55(11):1001-3. PubMed ID: 17090364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin initiation in Type 2 diabetes.
    Page S
    Diabet Med; 2005 Sep; 22 Suppl 4():2-5. PubMed ID: 16109011
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical characteristics of withdrawal from insulin therapy in NIDDM].
    Kanda T; Imano E; Iida M; Kawamori R
    Nihon Rinsho; 1997 Nov; 55 Suppl():727-32. PubMed ID: 9434555
    [No Abstract]   [Full Text] [Related]  

  • 17. The safety of sulfonylurea therapy in type 2 diabetes: have we reached the practical limits of our evidence base?
    Johnson JA
    Diabetologia; 2015 Jan; 58(1):1-3. PubMed ID: 25322844
    [No Abstract]   [Full Text] [Related]  

  • 18. [Sulfonylurea and alpha-glucosidase inhibitor].
    Iijima T
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():459-63. PubMed ID: 12387034
    [No Abstract]   [Full Text] [Related]  

  • 19. [Used of oral antidiabetic agents in pediatric patients - own observations].
    Stańczyk J; Otto-Buczkowska E; Jarosz-Chobot P; Nowowiejska B
    Endokrynol Pol; 2008; 59(5):434-43. PubMed ID: 18979454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful switch from insulin to oral sulfonylurea therapy in HNF1A-MODY Tunisian patient with the P291fsinsC mutation.
    Khelifa SB; Dendana A; Barboura I; Khochtali I; Chahed H; Ferchichi S; Miled A
    Diabetes Res Clin Pract; 2016 May; 115():133-6. PubMed ID: 26822262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.